Digital biomarkers could fundamentally change MS care: A study shows that wearables and smartphone tests reliably map disability (EDSS) and fatigue (FSMC) in everyday life. Motor performance data and heart rate variability allow progression to be detected earlier and could make treatment decisions much more precise in future.
Autoren
- Dr. Ulf Blanke
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Diabetic Polyneuropathy
Clinical Presentation, Diagnosis, and Treatment of DSPN
- The Brain and the Motivation to Eat
Why is it so hard to lose weight?
- From symptom to diagnosis
Pulmonology – Lobus venae acygos
- Atopic Dermatitis: Precisely Targeting Immunological Targets
Interleukin blockade or OX40-(L) inhibition?
- Fibromyalgia Syndrome
Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
- Across All Types of Cancer
Four-Legged Medical Assistants – Therapy Dogs in Clinical Settings
- Obesity: More than half of those affected have fatty liver disease
From screening to multimodal intervention with GLP-1-RA or resmetirom
- Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib